| CAS No. | 147059-72-1 |
|---|---|
| MDL No. | MFCD00871697 |
| MF | C20H15F3N4O3 |
| MW | 416.40 |
| InChI Key | WVPSKSLAZQPAKQ-SOSAQKQKSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 1 mg | 99.21% ; | $81 | In Stock | |
| 5 mg | 98% | $186 | In Stock | |
| 10 mg | 98% | $270 | In Stock | |
| 50 mg | 99.21% ; | $1210 | In Stock | |
| 100 mg | 99.21% ; | $1694 | In Stock | |
| 200 mg | 99.21% ; | $2285 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Trovafloxacin is a 1,8-naphthyridine derivative, specifically 4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid, bearing substituents: 2,4-difluorophenyl at position 1, fluoro at position 6, and 6-amino-3-azabicyclo[3.1.0]hex-3-yl at position 7. It is a broad-spectrum antibiotic that was withdrawn due to risk of liver failure. It functions as an antimicrobial agent, hepatotoxic agent, topoisomerase IV inhibitor, DNA synthesis inhibitor, and antibacterial drug. It is classified as a 1,8-naphthyridine derivative, amino acid, monocarboxylic acid, azabicycloalkane, tertiary amino compound, primary amino compound, quinolone antibiotic, fluoroquinolone antibiotic, and difluorobenzene. It is the conjugate base of trovafloxacin(1+).
| CAS No. | 147059-72-1 |
|---|---|
| Product Name | 1,8-Naphthyridine-3-carboxylic acid, 7-(1alpha,5alpha,6alpha)-6-amino-3-azabicyclo3.1.0hex-3-yl-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo- |
